CLEVELAND, Ohio — A genomic test used to assess prostate cancer risk may also help doctors determine which patients are ...

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

Having been diagnosed with prostate cancer is not the complete story. For one, it could mean that the patient’s prostate ...

Improvements in the PSA screening process make it worth another look.

UCL trial of 6,000 prostate cancer patients found the Decipher genetic test indicates which tumours are going to spread amid ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...

A new test can identify men who are more at risk of dying from prostate cancer and allow for more personalised treatment.

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...

Add Yahoo as a preferred source to see more of our stories on Google. Prostate cancer blood tests ‘can lead to men being over-tested’, experts say Prostate cancer blood tests can lead to men being ...